AXIM Biotech to Attend BioCentury’s 25th Annual Future Leaders in the Biotech Industry Conference in New York
March 21, 2018 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that George E....
AXIM Biotechnologies Reports Year End 2017 Results
March 19, 2018 16:15 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, March 19, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced financial results for...
IGC Partners to Advance Cannabinoid Based Parkinson's Disease Therapy Research -- CFN Media
March 14, 2018 09:00 ET
|
CFN Media
Seattle, WA , March 14, 2018 (GLOBE NEWSWIRE) -- CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article...
NEMUS Bioscience to Participate in Sachs BioCapital USA Forum at the New York Academy of Sciences
March 07, 2018 08:30 ET
|
Nemus Bioscience, Inc.
COSTA MESA, CA., March 07, 2018 (GLOBE NEWSWIRE) -- NEMUS Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical indications,...
Naturally Splendid Sells Manufacturing Stake to Refocus Efforts -- CFN Media
March 05, 2018 08:30 ET
|
CFN Media
SEATTLE, WA, March 05, 2018 (GLOBE NEWSWIRE) -- CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article...
AXIM Biotech Announces First-Ever Successful Achievement of Proprietary cGMP Extraction and Manufacturing Methods for Pure Cannabinoid Molecules
February 27, 2018 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Feb. 27, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies (OTC:AXIM) (“AXIM”), the world leader in cannabinoid research and development, today announced the first-ever successful execution...
CBS News Covers AXIM Biotech’s Patent Filing for Controlled-Release Chewing Gum to Provide Treatment for Opioid Addiction
February 21, 2018 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Feb. 21, 2018 (GLOBE NEWSWIRE) --
AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTCQB:AXIM), a world leader in cannabinoid research and development, today announced that CBS News...
NanoSphere Health Offers Six-Fold Improvement in Cannabinoid Bioavailability -- CFN Media
February 14, 2018 08:30 ET
|
CFN Media
SEATTLE, Feb. 14, 2018 (GLOBE NEWSWIRE) -- CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article covering...
Medipure Pharmaceuticals Inc. Announces Appointment of Dr. Kaiji Hu as Research Scientist - Cell and Molecular Biology
February 06, 2018 09:00 ET
|
Medipure Pharmaceuticals Inc.
VANCOUVER, British Columbia, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Medipure Pharmaceuticals Inc., a biopharmaceutical incubator committed to discovering and developing proprietary cannabinoid-derived...
Cannabis Science Expands Cancer Portfolio to Include Leukemia Treatment Research Utilizing Cannabinoid-Based Medicines
January 31, 2018 14:28 ET
|
Cannabis Science, Inc.
IRVINE, CA , Jan. 31, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces that the Company’s...